Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19

Mwansa Jere1, Vikki Garrick1, Lee Curtis1

  • 1Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow, UK.

Insights

Home faecal calprotectin testing provided a valuable alternative during the COVID-19 pandemic for paediatric inflammatory bowel disease (IBD) services. This method effectively guided clinical management and was preferred by most patients over traditional lab tests.

Area of Science:

  • Gastroenterology
  • Pediatrics
  • Clinical Diagnostics

Background:

  • COVID-19 pandemic disrupted standard pediatric inflammatory bowel disease (IBD) services.
  • Disruption necessitated alternative methods for essential diagnostic testing.

Purpose of the Study:

  • To audit the initial use of home fecal calprotectin testing in pediatric IBD patients.
  • To evaluate home testing as a viable alternative to laboratory-based assays.
  • To assess the potential for integrating home testing into routine IBD care.

Main Methods:

  • Prospective audit of home fecal calprotectin test kit usage from April to August 2020.
  • Kits provided to pediatric IBD patients requiring fecal calprotectin testing.
  • Automated result upload and clinical staff alerts; user feedback collected via questionnaire.

Main Results:

  • 41 out of 54 (76%) pediatric patients utilized home testing.
  • 12 (29%) patients had management decisions altered based on home test results.
  • 85% of questionnaire respondents preferred home testing over laboratory methods.

Conclusions:

  • Home fecal calprotectin testing proved effective in guiding pediatric IBD management when lab services were limited.
  • This approach may enhance routine monitoring, optimize appointments, and reduce hospital visits.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
476
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.2K
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
536
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
529
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
259